Owlstone Medical Secures Funding To Develop Its Breath Biopsy Technology
Executive Summary
The oversubscribed $58m funding round will enable the company to further work on its first-in-class breath biopsy technology, which aims to provide a cheap and convenient screening tool for several diseases.